A role for the putative tumor suppressor Bin1 in muscle cell differentiation

Molecular and Cellular Biology

Volumn 18, Issue 1, 1998, Pages 566-575

  Wechsler Reya, Robert J ^a,b   Elliott, Katherine J ^a   Prendergast, George C ^a  

^a WISTAR INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REPRESSOR PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE OVEREXPRESSION; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ANIMALIA; MURINAE;

EID: 0031983464     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.1.566     Document Type: Article

References (48)

1. Alemà, S., and F. Tatò. 1994. Oncogenes and muscle differentiation: multiple mechanisms of interference. Semin. Cancer Biol. 5:147-156.
2. Andrés, V., and K. Walsh. 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132:657-666.
3. Bader, D., T. Masaki, and D. A. Fischman. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95:763-770.
4. Bar-Sagi, U., and J. Schlessinger. 1994. Activation of Ras and other signaling pathways by receptor tyrosine kinases. Cold Spring Harbor Symp. Quant. Biol. 59:173-179.
5. Bauer, F., M. Urdaci, M. Aigle, and M. Crouzet. 1993. Alteration of a yeast SH3 protein leads to conditional viability with defects in cytoskeletal and budding patterns. Mol. Cell. Biol. 13:5070-5084.
6. Blau, H. M., G. K. Pavlath, E. C. Hardeman, C. P. Chiu, L. Silberstein, S. G. Webster, S. C. Miller, and C. Webster. 1985. Plasticity of the differentiated state. Science 230:758-766.
7. Borden, E. C., R. Lotan, D. Levens, C. W. Young, and S. Waxman. 1993. Differentiation therapy of cancer: laboratory and clinical investigations. Cancer Res. 53:4109-4115.
8. Boulikas, T. 1993. Nuclear localization signals. Crit. Rev. Eukarytic Gene Expr. 3:193-227.
9. Breitman, T. R., Z. X. Chen, and N. Takahashi. 1994. Potential applications of cytodifferentiation therapy in hematologic malignancies. Semin. Hematol. 31:18-25.
10. Butler, M. H., C. David, G.-C. Ochoa, Z. Freyberg, L. Daniell, D. Grabs, O. Cremona, and P. De Camilli. 1997. Amphiphysin II (SH3P9; BIN1), a member of the amphiphysin/RVS family, is concentrated in the cortical cytomatrix of axon initial segments and nodes of Ravier in brain and around T tubules in skeletal muscle. J. Cell Biol. 137:1355-1367.
11. Carriaga, M. T., and D. E. Henson. 1995. The histologic grading of cancer. Cancer 75:406-421.
12. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
13. Cher, M. L., G. S. Bova, D. H. Moore, E. J. Small, P. R. Carroll, S. S. Pin, J. I. Epstein, W. B. Isaacs, and R. H. Jensen. 1996. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res. 56: 3091-3102.
14. Collins, S. J., R. C. Gallo, and R. E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347-349.
15. Crescenzi, M., D. H. Crouch, and F. Tatò. 1994. Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells. J. Cell Biol. 125:1137-1145.
16. Denis, N., S. Blanc, M. P. Leibovitch, N. Nicolaiew, F. Dautry, M. Raymondjean, J. Kruh, and A. Kitzis. 1987. c-myc oncogene expression inhibits the initiation of myogenic differentiation. Exp. Cell Res. 172:212-217.
17. Dyson, N. 1994. pRB, p107 and the regulation of the E2F transcription factor. J. Cell Sci. 18(Suppl.):81-87.
18. Eckner, R., T.-P. Yao, E. Oldread, and D. M. Livingston. 1996. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:2478-2490.
19. Elliott, K., D. Sakamuro, W. Du, and G. C. Prendergast. Bin1 inhibits Myc transactivation and cell proliferation by diverse mechanisms.
20. Gu, W., K. Bhatia, I. T. Magrath, C. V. Dang, and R. DallaFavera. 1994. Binding and suppression of the myc transcriptional activation domain by p107. Science 264:251-254.
21. Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
22. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
23. Harper, J. W., and S. J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:56-64.
24. Huebner, K., M. Ohta, J. Lubinski, D. Berd, and H. C. Maguire. 1996. Detection of specific genetic alterations in cancer cells. Semin. Oncol. 23: 22-30.
25. Hunter, T. 1997. Oncoprotein networks. Cell 88:333-346.
26. Jones, C. L., and M. A. Kane. 1996. Oncogenic signaling. Curr. Opin. Oncol. 8:54-59.
27. La Rocca, S. A., D. H. Crouch, and D. A. F. Gillespie. 1994. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene 9:3499-3508.
28. Negorev, D., H. Reithman, R. Wechsler-Reya, D. Sakamuro, G. C. Prendergast, and D. Simon. 1996. The Bin1 gene localizes to human chromosome 2q1.4 by PCR analysis of somatic cell hybrids and fluorescence in situ hybridization. Genomics 33:329-331.
29. Olson, E. N. 1992. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154:261-272.
30. Ramjaun, A. R., K. D. Micheva, I. Bouchelet, and P. S. McPherson. 1997. Identification and characterization of a nerve terminal-enriched amphiphysin isoform. J. Biol. Chem. 272:16700-16706.
31. Raza, A., N. Yousuf, S. A. J. Bokhari, A. Mehdi, M. Masterson, B. Lampkin, G. Yanik, C. Mazewski, S. Khan, and H. Preisler. 1992. Contribution of in vivo proliferation/differentiation studies toward the development of a combined functional and morphologic system of classification of neoplastic diseases. Cancer 69:1557-1566.
32. Roskelley, C. D., A. Srebrow, and M. J. Bissell. 1995. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr. Opin. Cell Biol. 7:736-747.
33. Rowe, F., R. Buccafusca, and G. C. Prendergast. Unpublished data.
34. Sachs, L. 1996. The control of hematopoiesis and leukemia: from basic biology to the clinic. Proc. Natl. Acad. Sci. USA 93:4742-4749.
35. Sakamuro, D., K. Elliott, R. Wechsler-Reya, and G. C. Prendergast. 1996. BIN1 is a novel MYC-interacting protein with features of a tumor suppressor. Nature Genet. 14:69-77.
36. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., vol. I. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
37. Sejersen, T., J. Sumegi, and N. R. Ringertz. 1985. Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiation-defective myoblasts. J. Cell Physiol. 125: 465-470.
38. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024.
39. Slack, R. S., and F. D. Miller. 1996. Retinoblastoma gene in mouse neural development. Dev. Genet. 18:81-91.
40. Soddu, S., G. Blandino, R. Scardigli, S. Coen, A. Marchetti, M. G. Rizzo, G. Bossi, L. Cimino, M. Crescenzi, and A. Sacchi. 1996. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol. 134: 193-204.
41. Sparks, A. B., N. G. Hoffman, S. J. McConnell, D. M. Fowlkes, and B. K. Kay. 1996. Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins. Nat. Biotechnol. 14:741-744.
42. Tiainen, M., D. Spitkovsky, P. Jansen-Dürr, A. Sacchi, and M. Crescenzi. 1996. Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms. Mol. Cell. Biol. 16:5302-5312.
43. Tsutsui, K., Y. Maeda, K. Tsutsui, S. Seki, and A. Tokunaga. 1997. cDNA cloning of a novel amphiphysin isoform and tissue-specific expression of its multiple splice variants. Biochem. Biophys. Res. Commun. 236:178-183.
44. Wang, J., and B. Nadal-Ginard. 1995. Regulation of cyclins and p34cdc2 expression during terminal differentiation of C2C12 myocytes. Biochem. Biophys. Res. Commun. 206:82-88.
45. Webster, K. A., G. E. Muscat, and L. Kedes. 1988. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature 332:553-557.
46. Wechsler-Reya, R. Unpublished data.
47. Wechsler-Reya, R., K. Elliott, M. Herlyn, and G. C. Prendergast. 1997. The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein whose localization is altered in malignant cells. Cancer Res. 57:3258-3263.
48. Wechsler-Reya, R., D. Sakamuro, J. Zhang, J. DuHadaway, and G. C. Prendergast. 1998. Structural analysis of the human BIN1 gene: evidence of tissue-specific transcriptional regulation and alternate RNA splicing. J. Biol. Chem., in press.